Janus kinase inhibitors: efficacy and safety.

Current opinion in rheumatology(2023)

引用 0|浏览1
暂无评分
摘要
JAK inhibitors are effective treatments for RA. Issues have been raised regarding safety in patients with an increase in cardiovascular risk and VTE risk resulting in the need for risk stratification.
更多
查看译文
关键词
kinase,inhibitors,janus,efficacy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要